CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer
Claudin 18 isoform 2–targeted chimeric antigen receptor T-cell therapy significantly prolongs time to disease progression in patients with refractory gastric or gastroesophageal junction cancer. Medscape Medical News source https://www.medscape.com/viewarticle/car-t-cell-therapy-boosts-pfs-advanced-gastric-cancer-2025a1000eqm?src=rss